These neutrophils can effectively inhibit the anti-tumor activity of CD8+ T cells in HCC patients and promote the irreversible functional exhaustion of T cells, thereby causing the tumor to develop resistance to anti-PD-1 treatment [63]. This evidence concerns the gene CD8A and hepatocellular carcinoma.